Davies Julian,Magrini Fabio,Martin Andrea Paula,Mozaffarian Neelufar,Patel Chetankumar Natvarlal,Schroeder Oliver
申请号:
NZ72251815
公开号:
NZ722518A
申请日:
2015.03.13
申请国别(地区):
NZ
年份:
2017
代理人:
摘要:
The invention relates to engineered, humanized antibodies that have high binding affinity for and neutralize human IL-21, methods of using the antibodies to treat conditions in which antagonism or neutralization of the effects of IL-21 is warranted, such as autoimmune conditions, compositions and methods for recombinantly producing the antibodies, and pharmaceutical compositions comprising the antibodies.